Stephen Forman is listed as a director on 2 SEC Form D filings by 1 issuer between Dec 2018 and Aug 2023: LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Pasadena, CA — biotechnology — 2018–2023; $4.5M reported sold to 28 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside John S. Kovach (2 shared filings), Bas van der Baan (1 shared filing), Eric Forman (1 shared filing), James Miser (1 shared filing), Philip F. Palmedo (1 shared filing) and 6 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Stephen. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 court case matching the name, 5 bankruptcy cases matching the name listed in Key records below.
What this means 6 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 2 public filings for Stephen Forman and found 2 differences: Address moved from East Setauket, NY to Pasadena, CA; Stephen Forman is listed with 2 different address states: NY, CA.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.